Market Value1,779,485,386
Total Holdings57
File Date2023-02-10
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ZFOX / ZeroFox Holdings, Inc.
AKUS / Akouos Inc
GERN / Geron Corporation
ACRV / Acrivon Therapeutics, Inc.
GLYC / GlycoMimetics, Inc.
CTIC / CTI BioPharma Corp
AIRSPAN NETWORKS HOLDINGS INC / *W EXP 08/13/2023 (00951K146)
AIRSPAN NETWORKS HOLDINGS INC / *W EXP 08/13/2023 (00951K120)
MIMO.WSB / Airspan Networks Holdings Inc. Warrants, each whole warrant exercisable for one share of common stoc
CELC / Celcuity Inc.
BHG / Bright Health Group, Inc.
SNTI / Senti Biosciences, Inc.
EAR / Eargo, Inc.
OBSV / ObsEva SA.
NN / NextNav Inc.
CVRX / CVRx, Inc.
IVA / Inventiva S.A. - Depositary Receipt (Common Stock)
MEIP / MEI Pharma, Inc.
BILL / BILL Holdings, Inc.
NOTE / FiscalNote Holdings, Inc.
PANW / Palo Alto Networks, Inc.
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
OYST / Oyster Point Pharma Inc
US0846561076 / Berkshire Grey, Inc.
XERS / Xeris Biopharma Holdings, Inc.
LXRX / Lexicon Pharmaceuticals, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
NET / Cloudflare, Inc.
AVEO / AVEO Pharmaceuticals Inc
AFMD / Affimed N.V.
PHAS / PhaseBio Pharmaceuticals Inc
MIMO / Airspan Networks Holdings Inc.
CRSP / CRISPR Therapeutics AG
BZFD / BuzzFeed, Inc.
DMYI.U / dMY Technology Group, Inc. III Units, each consisting of one share of Class A common stock and one-f
STSA / Satsuma Pharmaceuticals Inc
SYBX / Synlogic, Inc.
TRVI / Trevi Therapeutics, Inc.
BDTX / Black Diamond Therapeutics, Inc.
CSBR / Champions Oncology, Inc.
TCON / TRACON Pharmaceuticals, Inc.
MRKR / Marker Therapeutics, Inc.
NKTX / Nkarta, Inc.
INZY / Inozyme Pharma, Inc.
ALLK / Allakos Inc.
UP / Wheels Up Experience Inc.
ADXN / Addex Therapeutics Ltd - Depositary Receipt (Common Stock)
UTRS / Minerva Surgical, Inc.
XFOR / X4 Pharmaceuticals, Inc.
COUR / Coursera, Inc.
GOSS / Gossamer Bio, Inc.
ACLX / Arcellx, Inc.
DM / Desktop Metal, Inc.
GLUE / Monte Rosa Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
TUYA / Tuya Inc. - Depositary Receipt (Common Stock)
RGLS / Regulus Therapeutics Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
AUPH / Aurinia Pharmaceuticals Inc.
RPHM / Reneo Pharmaceuticals, Inc.
SVRA / Savara Inc.